Peking University Medicine: Received the "Notice of Approval for Marketing Application of Chemical Raw Material Drugs"

K-LinePoet · 2026-03-29T03:13:21+00:00

Peking University Medicine announced that recently, the company received the "Approval Notice for the Listing Application of Chemical Raw Material Drugs" issued by the National Medical Products Administration. The generic name of the drug is Paliperidone, which is the main active metabolite of Risperidone. It is a second-generation antipsychotic drug mainly used for the treatment of schizophrenia in adults and adolescents aged 12-17 (weighing ≥29Kg).

K-LinePoet

2026-03-29 03:13:21

Peking University Medicine Announcement: Recently, the company received the “Approval Notice for the Application for Listing of Chemical Raw Materials” issued by the National Medical Products Administration. The drug’s generic name is Paliperidone, which is the main active metabolite of Risperidone. It is a second-generation antipsychotic medication, primarily indicated for the treatment of schizophrenia in adults and adolescents aged 12-17 years (weighing ≥29Kg).

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes